Can community coalitions slash HIV rates in the south?
NCT ID NCT05075967
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a community-based approach to lower HIV rates among men who have sex with men (MSM) at highest risk in the southern United States. The strategy uses local coalitions to reduce barriers, promote testing, increase PrEP use, and improve care for those living with HIV. About 2,700 participants will be involved, and the goal is to see if this integrated plan boosts access to prevention and treatment services.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Health Access Coalitions (community coalition program)
What this could lead to
If successful, this could provide a proven community-led model to reduce new HIV infections among the most at-risk men in the American South.
What could go wrong
This is a large but early-stage behavioral study without a control group, so it's hard to know if changes are due to the strategy or other factors. Results may not apply to other regions or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FHI 360
Durham, North Carolina, 27701, United States